DEL BELLO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.911
EU - Europa 7.017
AS - Asia 6.099
SA - Sud America 712
AF - Africa 252
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 44
Totale 28.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.458
CN - Cina 2.339
SG - Singapore 1.800
IT - Italia 1.587
RU - Federazione Russa 1.532
DE - Germania 939
PL - Polonia 711
BR - Brasile 581
VN - Vietnam 532
HK - Hong Kong 494
GB - Regno Unito 381
UA - Ucraina 368
CA - Canada 361
FR - Francia 355
SE - Svezia 320
FI - Finlandia 311
ZA - Sudafrica 175
TR - Turchia 170
KR - Corea 154
IN - India 146
IE - Irlanda 115
BD - Bangladesh 100
JP - Giappone 88
CZ - Repubblica Ceca 82
NL - Olanda 67
MX - Messico 61
BE - Belgio 60
PK - Pakistan 51
AR - Argentina 50
AU - Australia 49
ES - Italia 47
EU - Europa 38
IQ - Iraq 35
IR - Iran 32
EG - Egitto 28
AT - Austria 23
EC - Ecuador 20
ID - Indonesia 20
MY - Malesia 19
SA - Arabia Saudita 17
UY - Uruguay 15
HR - Croazia 14
PT - Portogallo 14
LT - Lituania 13
PE - Perù 12
RO - Romania 11
TW - Taiwan 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 10
KE - Kenya 10
BY - Bielorussia 9
CO - Colombia 9
HU - Ungheria 9
PH - Filippine 9
CH - Svizzera 8
CL - Cile 8
GR - Grecia 8
MA - Marocco 8
UZ - Uzbekistan 8
NP - Nepal 7
AL - Albania 6
AZ - Azerbaigian 6
JM - Giamaica 6
KG - Kirghizistan 6
PS - Palestinian Territory 6
RS - Serbia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DK - Danimarca 5
DZ - Algeria 5
HN - Honduras 5
IL - Israele 5
JO - Giordania 5
LV - Lettonia 5
TH - Thailandia 5
TN - Tunisia 5
KH - Cambogia 4
QA - Qatar 4
SN - Senegal 4
TT - Trinidad e Tobago 4
GE - Georgia 3
LK - Sri Lanka 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
PY - Paraguay 3
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
GH - Ghana 2
GT - Guatemala 2
IS - Islanda 2
LB - Libano 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
Totale 28.065
Salva come PNG Salva come JPEG
Città #
Dallas 1.313
Ashburn 1.084
Singapore 942
Fairfield 925
Jacksonville 865
Woodbridge 819
San Jose 701
Chandler 602
Warsaw 578
Houston 523
Ann Arbor 518
Hong Kong 473
Wilmington 458
Boardman 423
Beijing 404
Seattle 373
Camerino 353
Cambridge 293
Nanjing 275
New York 238
Toronto 235
Los Angeles 231
Dearborn 203
Council Bluffs 199
Ho Chi Minh City 176
Helsinki 166
Johannesburg 158
The Dalles 155
Seoul 144
San Mateo 140
Tongling 139
Lawrence 130
Princeton 129
Istanbul 123
Lauterbourg 122
Hanoi 121
Dublin 116
Kraków 113
Columbus 111
Munich 111
Santa Clara 105
Nanchang 104
Orem 102
Ogden 96
Moscow 95
London 94
Düsseldorf 93
Buffalo 92
Milan 89
Shanghai 74
Tokyo 68
Shenyang 67
Guangzhou 64
São Paulo 60
Jiaxing 57
Kunming 57
Brno 56
Rome 55
Chicago 54
Brussels 52
Frankfurt am Main 51
Trieste 51
Lachine 50
Jinan 49
Tianjin 48
Turku 47
Chennai 46
San Diego 46
Manchester 41
Changsha 40
Hebei 39
Phoenix 39
Bremen 38
Centro 36
St Louis 36
Philadelphia 35
Montreal 34
Brooklyn 33
Hangzhou 33
Zhengzhou 33
Denver 32
Stockholm 30
Ascoli Piceno 29
Dong Ket 29
Redondo Beach 29
Wuhan 29
Da Nang 27
Mexico City 27
Poplar 27
Redwood City 27
Nuremberg 25
Venezia 25
Ningbo 24
Haiphong 23
Amsterdam 22
Hefei 22
Perugia 22
Atlanta 21
Leawood 21
Mumbai 21
Totale 18.053
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 645
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 623
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 622
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 560
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 531
1,4-Dioxane Nucleus as a Suitable Scaffold for the Characterization of Different Receptor Systems 358
An Efficient Lewis Acid Catalyzed Povarov Reaction for the One-Pot Stereocontrolled Synthesis of Polyfunctionalized Tetrahydroquinolines 344
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 339
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 332
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 327
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 323
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 312
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 304
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation 302
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 299
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 294
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine 291
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 290
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 268
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 263
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 254
Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms 252
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 250
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 247
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation 243
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 241
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 241
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 238
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 227
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 226
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 219
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 218
Biguanide derivatives as surfactants and antimicrobial agents for pharmaceutical applications 218
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 217
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 216
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 212
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 212
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 211
Adenosine receptors as promising targets for the management of ocular diseases 210
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 209
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 207
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats 207
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 206
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 205
New insights in Au-NHCs complexes as anticancer agents 204
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 200
Complessi di rame(I) con leganti tris(azolil)borati e fosfine monodentate: sintesi e studi biologici 199
BIOLOGICAL PROFILE AND BIOAVAILABILITY OF IMIDAZOLINE COMPOUNDS AFFECT THEIR MODULATORY ACTIVITY ON MORPHINE TOLERANCE 198
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 197
4WD to Travel Inside the 5-HT1A Receptor World 197
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 196
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 195
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 193
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 193
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 192
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 192
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 191
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 190
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders 189
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 189
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 188
Effects of imidazoline I2 receptor ligands on acute nociception in rats 187
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 186
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 186
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 184
Front Cover, European Journal of Medicinal, Issue 146, 25 February 2018. 184
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 183
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 181
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 180
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 178
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma 178
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 177
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 176
Activation of primary amines by copper(I)-based Lewis acid promoters in the solventless synthesis of secondary propargylamines 173
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 173
Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility 172
Efficient Lewis Acid Systems for the A3 Coupling reaction 172
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 171
MORPHINE TOLERANCE MODULATION INDUCED BY alpha2-ADRENERGIC OR/AND I2 IMIDAZOLINE BINDING SITES LIGANDS 169
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9.From 1,4-benzodioxan to 1,4-dioxane ring as a promising template of novel alpha(1D)-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 169
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 168
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 167
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 166
From benzodioxane to 1,4-dioxane scaffold in the design of 5-HT1A serotoninergic full agonists from α1-adrenergic antagonists 164
Imidazoline nucleus as a biologically versatile scaffold 162
Design, synthesis, reactivity, biological and catalytic applications of functionalized bis(pyrazolyl)acetate copper complexes 158
Effects of allyphenyline on chronic alcohol intoxication model 157
NOVEL IMIDAZOLINE MOLECULES INSPIRED BY THE PHARMACOLOGICAL PROFILE OF AGMATINE AS POTENTIAL TOOLS IN MANAGING OPIOID ADDICTION 153
Hybrid molecules from xanomeline and 77-LH-28-1 as potential novel M1 muscarinic agonists 151
Trekking through receptor chemistry 150
Chemistry and antitumor investigations of new Cu(I) complexes of bis(pyrazol-1-yl)acetate ligands functionalized with an NMDA receptor antagonist 147
A Versatile Continuous Fluorometric Enzymatic Assay for Targeting Nicotinate Phosphoribosyltransferase 144
Design and synthesis of novel imidazoline derivatives potentially targeting dopamine receptors 143
Molecular determinants in the binding of novel 1,4-benzodioxan-related α1D-adrenergic receptor antagonists: a computational study 141
Synthesis, reactivity and biological studies of bioconjugated bis(pyrazolyl)acetate copper complexes 141
Aminopyrimidines as inhibitors of the Wnt signalling pathway 140
Enantiomers of 6,6-diphenyl-1,4-dioxane derivatives to highlight stereochemical requirements for selective alpha1D-AR and 5- HT1A receptor recognition 136
Copresence of 1,4-dioxane and quinuclidine nuclei in the design of novel muscarinic antagonists 135
null 132
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 131
Totale 22.681
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.721
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021233 0 0 0 0 0 0 0 0 0 0 0 233
2021/20221.428 122 359 38 58 93 63 46 111 122 165 85 166
2022/20231.867 232 71 89 237 186 214 20 118 360 106 152 82
2023/20241.608 195 94 131 52 68 175 76 57 159 62 43 496
2024/20255.106 241 110 424 246 192 265 602 1.166 433 324 333 770
2025/20268.907 490 574 1.601 1.180 804 577 1.237 603 511 590 550 190
Totale 28.608